Pharmaceutical News and Articles

Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)

CKD May Be Tied to Higher Risk for Tooth Loss

Chronic kidney disease (CKD) appears to be associated with a higher risk for tooth loss, with a higher prevalence of CKD seen among individuals with fewer than

More Than Half of Infants Diagnosed With HIV Did Not Receive Postnatal HIV Prophylaxis

Although the rate of perinatal HIV infection is low, more than 50 percent of HIV infections in infants before age 1 year occurred in those who did not receive p

Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods

The U.S. Department of Health and Human Services, U.S. Department of Agriculture, and U.S. Food and Drug Administration are gathering data to create a uniform d

Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events, according t

Fertility Rate Decreased 1 Percent From 2023 to 2024

From 2023 to 2024, there was a 1 percent increase in the number of births and a 1 percent decrease in the general fertility rate, according to a July data brief

Risk Has Doubled For Alcohol Liver Disease

THURSDAY, July 24, 2025 Heavy-drinking Americans are more than twice as likely to develop alcohol-related liver disease compared to two decades ago, even though

FDA Approves First Cream for Treating Chronic Hand Eczema, Anzupgo

THURSDAY, July 24, 2025 The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczem

Alopecia Areata Associated With Severe Psychosocial Impact

Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity, according to a stu

Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis

For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality, according to a